Empaa 10mg Tablets 28s – Empagliflozin for Type 2 Diabetes
- Contains Empagliflozin 10mg — an SGLT2 inhibitor for type 2 diabetes.
- Lowers blood glucose by promoting urinary glucose excretion.
- Reduces risk of cardiovascular complications and heart failure hospitalisation.
- Slows progression of diabetic chronic kidney disease.
- Prescription Required. Not for type 1 diabetes. Available at Derma.pk with valid prescription.
Pay in 3 Installments of
Rs.
375
Empaa 10mg Tablets 28s – Empagliflozin for Type 2 Diabetes
Description
Empaa 10mg Tablets – Empagliflozin SGLT2 Inhibitor for Type 2 Diabetes
Prescription Required. Available at Derma.pk with valid prescription.
Empaa 10mg contains Empagliflozin, a modern SGLT2 (sodium-glucose co-transporter-2) inhibitor prescribed for adults with type 2 diabetes mellitus to improve glycaemic control. By blocking SGLT2 in the renal proximal tubule, Empagliflozin promotes urinary glucose excretion, lowering blood sugar levels without causing hypoglycaemia in most patients.
Beyond glycaemic control, Empaa 10mg has demonstrated significant cardiovascular and renal benefits in clinical trials. It reduces the risk of hospitalisation for heart failure and slows the progression of chronic kidney disease in diabetic patients. For this reason it is often prescribed as part of a comprehensive diabetes management plan that targets both metabolic and organ-protective goals.
Important Clinical Notes
- Not for type 1 diabetes or diabetic ketoacidosis
- Monitor renal function (eGFR) before and during treatment
- Increased risk of urinary tract and genital infections — maintain good hygiene
- Avoid in patients with severe renal impairment (eGFR <30 mL/min/1.73m²)
- Can be used alone or in combination with metformin, sulphonylureas, or insulin
- Maintain adequate hydration to reduce risk of dehydration and hypotension
How to Order at Derma.pk
Submit your valid prescription via sales@derma.pk or WhatsApp +92-320-5999650. Fast delivery across Pakistan.
Usage & Benefits
- Blood Sugar Control: SGLT2 inhibition promotes renal glucose excretion, lowering HbA1c and fasting blood glucose in type 2 diabetes.
- Cardiovascular Protection: Clinically proven to reduce risk of heart failure hospitalisation and major adverse cardiovascular events.
- Kidney Protection: Slows progression of diabetic nephropathy and chronic kidney disease.
- Weight Benefit: Associated with modest weight reduction due to caloric loss from glucosuria.
- Blood Pressure: May modestly reduce systolic blood pressure as an additional benefit.
How To Use
1. Use as directed by your physician. Take one tablet once daily with or without food. Swallow whole with a glass of water. Monitor renal function (eGFR) and blood pressure regularly. Maintain adequate hydration. Do not stop without consulting your healthcare provider. A valid prescription is required. Not suitable for type 1 diabetes.
FAQs
What is Empaa 10mg used for?
Empaa 10mg is prescribed for blood sugar control in adults with type 2 diabetes mellitus and offers additional benefits for heart and kidney protection.
Can Empaa be used in type 1 diabetes?
No. Empagliflozin is not approved for type 1 diabetes and should not be used in this condition or in diabetic ketoacidosis.
Does Empaa cause low blood sugar (hypoglycaemia)?
On its own, Empaa rarely causes hypoglycaemia. However, if combined with insulin or sulphonylureas, the dose of those medicines may need to be reduced.
What monitoring is required?
Regular monitoring of renal function (eGFR), blood pressure, and blood sugar levels is recommended. Report any signs of urinary tract or genital infections to your doctor promptly.
Do I need a prescription?
Yes. Empaa 10mg is a prescription-only SGLT2 inhibitor. Submit via sales@derma.pk or WhatsApp +92-320-5999650.



